Aicuris GmbH & Co. KG

Allemagne

 
Quantité totale PI 87
Rang # Quantité totale PI 15 201
Note d'activité PI 2,4/5.0    35
Rang # Activité PI 21 706

Brevets

Marques

17 0
9 0
61 0
0
 
Dernier brevet 2024 - Maleate salt of the free base of...
Premier brevet 1999 - Interleukin-2 mutein expressed f...

Derniers inventions, produits et services

2024 Invention Maleate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2...
2022 Invention Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with ...
Invention Parapoxvirus for preparing for and treatment of respiratory syncytial virus infections. The inven...
2021 Invention Pdgfrα polypeptides as viral decoy receptors. The present invention relates to the field of pharm...
Invention Parapoxvirus for conditioning for and treatment of coronavirus infections. The present invention...
Invention Parapoxvirus for conditioning for and treatment of coronavirus infections. The present invention ...
Invention Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3- thiazol-2-yl]-n-methyl-2-[4-...
2020 Invention Novel indole-2-carboxamides active against the hepatitus b virus (hbv). The present invention re...
Invention Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv). The present inventio...
Invention Novel oxalyl piperazines active against the hepatitis b virus (hbv). The present invention relat...
Invention Novel phenyl and pyridyl ureas active against the hepatitis b virus (hbv). The present invention...
Invention Novel oxalyl piperazines active against the hepatitis b virus (hbv). The present invention relate...
Invention Novel phenyl and pyridyl ureas active against the hepatitis b virus (hbv). The present invention ...
Invention Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv). The present invention...
Invention Novel indole-2-carboxamides active against the hepatitis b virus (hbv). The present invention rel...
2019 Invention Novel 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine indole-2-carboxamides active against the hepatitis b...
Invention 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine indole-2-carboxamides active against the hepatitis b virus...
Invention Novel urea 6,7-dihydro-4h-pyrazolo[4,3-c]pyridines active against the hepatitis b virus (hbv). T...
Invention Novel urea 6,7-dihydro-4h-thiazole[5,4-c]pyridines active against the hepatitis b virus (hbv). T...
Invention Novel urea 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazines active against the hepatitis b virus (hbv). T...
Invention Novel urea 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazines active against the hepatitis b virus (hbv). Th...
Invention Novel urea 6,7-dihydro-4h-pyrazolo[4,3-c]pyridines active against the hepatitis b virus (hbv). Th...
Invention Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv). Th...
Invention Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex ...
Invention Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom. The inventi...
2018 Invention Highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis ...
Invention Highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b vir...
Invention Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hep...
Invention Combination therapies of hepatitis b virus (hbv)-infected individuals using parapoxvirus ovis (pp...
2017 Invention Combination therapy with amidine substituted beta-lactam compounds and beta-lactamase inhibitors ...
Invention Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodex...
Invention Liposomal formulations of amidine substituted beta-lactam compounds for use in the treatment of b...